Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy
Caroline Besson(Bicêtre Hospital), Martine Raphaël(University of Lausanne), Nicole Brousse(Hôpital Necker-Enfants Malades), M Tulliez(Inserm), Willy Rozenbaum, Dominique Costagliola(Inserm), Frédéric Charlotte(Sorbonne Université), J Mikol(Délégation Paris 7), Aïcha Goubar(Inserm), Philippe Camparo(Centre Hospitalier Universitaire Amiens-Picardie), B. Dupont(Délégation Paris 5), Karima Mokhtari(Inserm), Gilles Pialoux, F Châtelet(Inserm), François Boué(Inserm), Jean Gabarre(Inserm), Dominique Salmon‐Céron(Délégation Paris 5), Michel Huerre(Centre National de la Recherche Scientifique), Christine Katlama(Université Paris Cité)
Cited by 375
Related Papers
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
|Cell|2000|1.6k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k